ADVB (Advanced Biomed Corp) Kacepetan wutah bathi saben saham ing taun lumaku
The viability of Advanced Biomed Inc (ADVB) relies on the adoption rates of early diagnostics and the pursuit of investment. The volatility of annual earnings per share illustrates the impact of these factors, where 0.00 captures the current value of the indicator. Cost optimization is based on the robotization of tumor screening and strict adherence to cleanroom assembly standards during the disposal of chemical reagents.
Rincian metrik keuangan lan pasar advanbiomed.com (ADVB)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Advanced Biomed Inc|ADVB - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Advanced Biomed|ADVB - Utang perusahaan|Rasio utang marang nilai buku ADVB|ADVB - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Advanced Biomed|Likuiditas darurat advanbiomed.com
- rincian bathi lan kelipatan pasar:
ADVB - Bathi resik|Prakiraan bathi resik Advanced Biomed Inc|ADVB - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Advanced Biomed|ADVB - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ADVB|ADVB - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Advanced Biomed|ADVB - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan advanbiomed.com|ADVB - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Advanced Biomed Inc
Analisis dhasar perusahaan:Advanced Biomed Corp
For Advanced Biomed Inc (ADVB), earnings per share dynamics serve as an indicator of the effectiveness of monetizing scientific research. This metric calculates the percentage deviation of the current EPS from the value of the same period last year. By analyzing the annual EPS growth trajectory, an investor assesses the pace of business scaling. Growth in this indicator confirms the commercial demand for diagnostic oncology systems. A steady increase in profit verifies the transformation of high scientific potential into real financial results.
Pesaing langsung
BeiGene Ltd. - Tambahing bathi saben saham ing taun lumaku|HALO (Halozyme Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Revolution Medicines Corp RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi ing taun lumaku cgoncology.com (CGON)|Wutah bathi ing taun lumaku URGN (UroGen Pharma)|BCAX: Wutah bathi saben saham ing taun iki|PSNL: Wutah bathi resik saben saham ing taun iki|ERAS: Wutah bathi saben saham ing taun lumaku|DCTH: Wutah bathi ing taun lumaku|ymabs.com (YMAB) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Aura Biosciences|Wutah bathi saben saham ing taun iki CADL (Candel)|Wutah bathi ing taun lumaku ARAY|Wutah bathi resik saben saham ing taun iki sellaslifesciences.com SLS|Wutah bathi ing taun lumaku ACTU (Actuate Therapeutics, Inc.)|citiusonc.com (CTOR) - Kacepetan wutah bathi saben saham ing taun lumaku|TuHURA - Wutah bathi ing taun lumaku|TARA (Protara Therapeutics Inc) - Wutah bathi saben saham ing taun iki|FATE (Fate Therapeutics Corp) - Wutah bathi resik saben saham ing taun iki|Aadi Bioscience - Tambahing bathi saben saham ing taun lumaku|TCRX (TScan Therapeutics Inc) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku CSBR|Wutah bathi ing taun lumaku XBIT|Prakiraan wutah bathi resik saben saham ing taun iki cel-sci.com|Wutah bathi saben saham ing taun lumaku OS Therapies Inc OSTX|radiopharmtheranostics.com (RADX) - Kacepetan wutah bathi saben saham ing taun lumaku|ARTV - Wutah bathi saben saham ing taun lumaku|Adlai Nortye Ltd. (ANL) - Wutah bathi resik saben saham ing taun iki|VERU: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Tempest Therapeutics Inc (TPST)|XLO (Xilio Therapeutics Inc) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki RENB (Enochian BioSciences)|Wutah bathi resik saben saham ing taun iki MURA (Mural Oncology plc)|KAPA (kairospharma.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku OKUR (OnKure Therapeutics)|Prakiraan wutah bathi resik saben saham ing taun iki CytoMed Therapeutics Ltd (GDTC)|CRIS - Wutah bathi saben saham ing taun lumaku|APLM (Apollomics, Inc.) - Wutah bathi saben saham ing taun iki|THAR: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki genprex.com|CLDI (Calidi Biotherapeutics Inc.) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku sunshinebiopharma.com|Wutah bathi ing taun lumaku XBIO|Salarius Pharma - Wutah bathi saben saham ing taun iki|Purple Biotech - Wutah bathi resik saben saham ing taun iki|American Oncology Network Inc - Wutah bathi saben saham ing taun lumaku|BeiGene - Wutah bathi ing taun lumaku|CKPT: Wutah bathi saben saham ing taun lumaku|ELEV: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki iCAD|IKNA (Ikena Oncology Inc.) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku notablelabs.com|Wutah bathi saben saham ing taun lumaku Viracta Therapeutics (VIRX)|MorphoSys Inc - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku NAYA (NAYA Bio)|AAPGV - Wutah bathi resik saben saham ing taun iki
